2aog: Difference between revisions
Jump to navigation
Jump to search
m Protected "2aog" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2aog.png|left|200px]] | [[Image:2aog.png|left|200px]] | ||
{{STRUCTURE_2aog| PDB=2aog | SCENE= }} | {{STRUCTURE_2aog| PDB=2aog | SCENE= }} | ||
===Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC=== | ===Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC=== | ||
{{ABSTRACT_PUBMED_16218957}} | {{ABSTRACT_PUBMED_16218957}} | ||
==About this Structure== | ==About this Structure== | ||
[[2aog]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | [[2aog]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_type_1_(bh5_isolate) Human immunodeficiency virus type 1 (bh5 isolate)]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2AOG OCA]. | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:016218957</ref><references group="xtra"/> | <ref group="xtra">PMID:016218957</ref><references group="xtra"/> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Boross, P I.]] | [[Category: Boross, P I.]] | ||
[[Category: Chen, X.]] | [[Category: Chen, X.]] |
Revision as of 15:51, 27 February 2013
Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NCCrystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC
Template:ABSTRACT PUBMED 16218957
About this StructureAbout this Structure
2aog is a 2 chain structure with sequence from Human immunodeficiency virus type 1 (bh5 isolate). Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Tie Y, Boross PI, Wang YF, Gaddis L, Liu F, Chen X, Tozser J, Harrison RW, Weber IT. Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs. FEBS J. 2005 Oct;272(20):5265-77. PMID:16218957 doi:10.1111/j.1742-4658.2005.04923.x